期刊文献+

Effect of interferon plus ribavirin therapy on hepatitis C virus genotype 3 patients from Pakistan:Treatment response,side effects and future prospective

Effect of interferon plus ribavirin therapy on hepatitis C virus genotype 3 patients from Pakistan:Treatment response,side effects and future prospective
下载PDF
导出
摘要 More than 10 million people are suffering from hepatitis C virus(HCV) in Pakistan,The available treatment option is a combination of interferon and ribavirin.Treatment response is linked with several factors and also induces a number of side effects.We searched in Pubmed.Pak Medi Net and Coogle Scholar for the articles presenting the effect of interferon plus ribavirin therapy on HCV patients from Pakistan,their side effects and future prospects.The major prevalent HCV genotype in Pakistan is 3.Conventional interferon alpha plus ribavirin showed sustained virological response of 54%-64%while pegylaled interferon alpha plus ribavirin showed sustained virological response of 58%-75%.IL-28 B CC genotype is linked with better sustained virological response.Studies on patients with HCV genotype 3 infections showed no correlation between treatment response and interferon sensitivity determining region mutations.Interferon therapy is linked with a number of side effects like thyroid dysfuncton.hactnatological disorders,weight loss,gastrointestinal tract side effects and neuropsychiatric side effects.Unusual side effects of clubbing of fingers and seizures were also observed in a couple of patients.Interferon alpha plus ribavirin therapy showed better response rate in HCV genotype 3 patients from Pakistan with number of side effects.A couple of interferon free therapies are light of hope for the patients living with HCV. More than 10 million people are suffering from hepatitis C virus(HCV) in Pakistan,The available treatment option is a combination of interferon and ribavirin.Treatment response is linked with several factors and also induces a number of side effects.We searched in Pubmed.Pak Medi Net and Coogle Scholar for the articles presenting the effect of interferon plus ribavirin therapy on HCV patients from Pakistan,their side effects and future prospects.The major prevalent HCV genotype in Pakistan is 3.Conventional interferon alpha plus ribavirin showed sustained virological response of 54%-64%while pegylaled interferon alpha plus ribavirin showed sustained virological response of 58%-75%.IL-28 B CC genotype is linked with better sustained virological response.Studies on patients with HCV genotype 3 infections showed no correlation between treatment response and interferon sensitivity determining region mutations.Interferon therapy is linked with a number of side effects like thyroid dysfuncton.hactnatological disorders,weight loss,gastrointestinal tract side effects and neuropsychiatric side effects.Unusual side effects of clubbing of fingers and seizures were also observed in a couple of patients.Interferon alpha plus ribavirin therapy showed better response rate in HCV genotype 3 patients from Pakistan with number of side effects.A couple of interferon free therapies are light of hope for the patients living with HCV.
作者 Yasir Waheed
出处 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2015年第2期85-89,共5页 亚太热带医药杂志(英文版)
关键词 HEPATITIS C VIRUS INTERFERON THERAPY GENOTYPE 3 Hepatitis C virus Interferon therapy Genotype 3
  • 相关文献

参考文献19

  • 1Yasir Waheed,Talha Shafi,Sher Zaman Safi,Ishtiaq Qadri.Hepatitis C virus in Pakistan:A systematic review of prevalence,genotypes and risk factors[J].World Journal of Gastroenterology,2009,15(45):5647-5653. 被引量:12
  • 2H Le Guillou-Guillemette,S Vallet,C Gaudy-Graffin,C Payan,A Pivert,A Goudeau,F Lunel-Fabiani.Genetic diversity of the hepatitis C virus: Impact and issues inthe antiviral therapy[J].World Journal of Gastroenterology,2007,13(17):2416-2426. 被引量:6
  • 3Yasir Waheed,Attya Bhatti,Muhammad Ashraf.RNA dependent RNA polymerase of HCV: A potential target for the development of antiviral drugs[J]. Infection, Genetics and Evolution . 2013
  • 4Amina Nadeem,Muhammad Aslam,Alessandro Antonelli.Association of Interferon-Alpha and Ribavirin-Induced Thyroid Dysfunction with Severity of Disease and Response to Treatment in Pakistani Asian Patients of Chronic Hepatitis C[J]. <journal-title>Hepatitis Research and Treatment . 2012
  • 5Hafsa Aziz,Abida Raza,Yasir Waheed,Uzma Gill,Muzaffar Lateef Gill.Analysis of variables and interactions among variables associated with a sustained virological response to pegylated interferon alfa-2a plus ribavirin in hepatitis C virus genotype 3-infected patients[J]. International Journal of Infectious Diseases . 2012 (8)
  • 6Hafsa Aziz,Muzaffar Latif Gil,Yasir Waheed,Uzama Adeeb,Abida Raza,Iram Bilal,Muhammad Amin Athar.Evaluation of prognostic factors for Peg Interferon alfa-2b plus ribavirin treatment on HCV infected patients in Pakistan[J]. Infection, Genetics and Evolution . 2011 (3)
  • 7Furqaan Ahmed,Ira M. Jacobson,Jorge L. Herrera,Myron Brand,Ronald B. Wasserman,Alan M. Fixelle,Vinod K. Rustgi,Clive Albert,Robert Brown,Clifford Brass.Seizures During Pegylated Interferon and Ribavirin Therapy for Chronic Hepatitis C: Observations From the WIN-R Trial[J]. Journal of Clinical Gastroenterology . 2011 (3)
  • 8Meetings[J].World Journal of Gastroenterology,2010,16(1). 被引量:25
  • 9HarukiKomatsu,TomooFujisawa,AyanoInui,YoshihiroMiyagawa,MasahiroOnoue.Mutations in the nonstructural protein 5A gene and response to interferon therapy in young patients with chronic hepatitis C virus 1b infection[J]. J. Med. Virol. . 1998 (4)
  • 10Mansky L M,Bernard L C.3’-Azido-3’-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1. Journal of Virology . 2000

二级参考文献98

  • 1[57]Puig-Basagoiti F,Forns X,Furcic I,Ampurdanes S,Gimenez-Barcons M,Franco S,Sanchez-Tapias JM,Saiz JC.Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C.J Gen Virol 2005; 86:1067-1075
  • 2[58]Houghton M.Hepatitis C virus.In:Howley DMKPM.Fields Virology.Philadelphia:Lippincott-Raven,1996:1035-1058
  • 3[59]Farci P,Purcell RH.Clinical significance of hepatitis C virus genotypes and quasispecies.Semin Liver Dis 2000; 20:103-126
  • 4[60]Bartenschlager R.The NS3/4A proteinase of the hepatitis C virus:unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy.J Viral Hepat 1999; 6:165-181
  • 5[61]Vallet S,Gouriou S,Nousbaum JB,Legrand-Quillien MC,Goudeau A,Picard B.Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated infected patients.J Med Virol 2005; 75:528-537
  • 6[62]Vallet S,Gouriou S,Nkontchou G,Hotta H,Vilerio M,Legrand-Quillien MC,Beaugrand M,Trinchet JC,Nousbaum JB,Deny P,Gaudy C,Goudeau A,Picard B,Payan C.Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?J Viral Hepat 2007; 14:96-106
  • 7[63]Soderholm J,Ahlen G,Kaul A,Frelin L,Alheim M,Barnfield C,Liljestrom P,Weiland O,Milich DR,Bartenschlager R,Sallberg M.Relation between viral fitness and immune escape within the hepatitis C virus protease.Gut 2006; 55:266-274
  • 8[64]Gale M,Jr.Effector genes of interferon action against hepatitis C virus.Hepatology 2003; 37:975-978
  • 9[65]Meylan E,Curran J,Hofmann K,Moradpour D,Binder M,Bartenschlager R,Tschopp J.Cardif is an adaptor protein in the RIG-Ⅰ antiviral pathway and is targeted by hepatitis C virus.Nature 2005; 437:1167-1172
  • 10[66]Kieffer T,Sarrazin C,Bartels D,Hanzelka B,Müh U,Welker M,Wincheringer D,Lin C,Purdy S,Weegink C,Reesink H,Kwong A,Zeuzem S.Wild-type HCV NS3 protease reemerges during follow-up after 14 days of dosing with VX-950 in patients with genotype 1 HCV.In:Colombo M.Journal of Hepatology.EASL 2006:Proceedings of the 41th Annual Meeting of the European Association for the Study of the Liver; 2006 Apr 26-30; Vienna,Austria.Shannon,Ireland:Elsevier,2006:44:S7

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部